Latent tuberculosis infection: myths, models, and molecular mechanisms NK Dutta, PC Karakousis Microbiology and Molecular Biology Reviews 78 (3), 343-371, 2014 | 310 | 2014 |
Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice PC Karakousis, T Yoshimatsu, G Lamichhane, SC Woolwine, ... The Journal of experimental medicine 200 (5), 647-657, 2004 | 303 | 2004 |
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy PC Karakousis, RD Moore, RE Chaisson The Lancet infectious diseases 4 (9), 557-565, 2004 | 291 | 2004 |
Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues PC Karakousis, SK John, KC Behling, EM Surace, JE Smith, ... Mol Vis 7 (154), 63, 2001 | 247 | 2001 |
Mycobacterium tuberculosis cell envelope lipids and the host immune response PC Karakousis, WR Bishai, SE Dorman Cellular microbiology 6 (2), 105-116, 2004 | 229 | 2004 |
Tuberculosis-associated haemophagocytic syndrome PK Brastianos, JW Swanson, M Torbenson, J Sperati, PC Karakousis The Lancet infectious diseases 6 (7), 447-454, 2006 | 227 | 2006 |
Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo PP Singh, VL Smith, PC Karakousis, JS Schorey The Journal of Immunology 189 (2), 777-785, 2012 | 220 | 2012 |
Role of the dosR-dosS Two-Component Regulatory System in Mycobacterium tuberculosis Virulence in Three Animal Models PJ Converse, PC Karakousis, LG Klinkenberg, AK Kesavan, LH Ly, ... Infection and immunity 77 (3), 1230-1237, 2009 | 191 | 2009 |
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis V Chidambaram, NL Tun, WZ Haque, MG Majella, RK Sivakumar, ... PloS one 15 (11), e0241541, 2020 | 188 | 2020 |
Phosphate Depletion: A Novel Trigger for Mycobacterium tuberculosis Persistence D Rifat, WR Bishai, PC Karakousis The Journal of infectious diseases 200 (7), 1126-1135, 2009 | 184 | 2009 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis IM Rosenthal, R Tasneen, CA Peloquin, M Zhang, D Almeida, KE Mdluli, ... Antimicrobial agents and chemotherapy 56 (8), 4331-4340, 2012 | 166 | 2012 |
Development of a novel lead that targets M. tuberculosis polyketide synthase 13 A Aggarwal, MK Parai, N Shetty, D Wallis, L Woolhiser, C Hastings, ... Cell 170 (2), 249-259. e25, 2017 | 161 | 2017 |
Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions L Zhou, SK Ayeh, V Chidambaram, PC Karakousis BMC infectious diseases 21 (1), 496, 2021 | 157 | 2021 |
Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment NR Degner, JY Wang, JE Golub, PC Karakousis Clinical Infectious Diseases 66 (2), 198-205, 2018 | 153 | 2018 |
The Global Health Security Index is not predictive of coronavirus pandemic responses among Organization for Economic Cooperation and Development countries EJ Abbey, BAA Khalifa, MO Oduwole, SK Ayeh, RD Nudotor, EL Salia, ... PloS one 15 (10), e0239398, 2020 | 150 | 2020 |
Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis PC Karakousis, EP Williams, WR Bishai Journal of antimicrobial chemotherapy 61 (2), 323-331, 2008 | 134 | 2008 |
Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug-Tolerant, Not Drug-Resistant, Mycobacterium tuberculosis in the Guinea Pig Z Ahmad, LG Klinkenberg, ML Pinn, MM Fraig, CA Peloquin, WR Bishai, ... The Journal of infectious diseases 200 (7), 1136-1143, 2009 | 131 | 2009 |
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen C Skerry, ML Pinn, N Bruiners, R Pine, ML Gennaro, PC Karakousis Journal of Antimicrobial Chemotherapy 69 (9), 2453-2457, 2014 | 127 | 2014 |
Roles of SigB and SigF in the Mycobacterium tuberculosis Sigma Factor Network JH Lee, PC Karakousis, WR Bishai Journal of bacteriology 190 (2), 699-707, 2008 | 124 | 2008 |
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence NK Dutta, LG Klinkenberg, MJ Vazquez, D Segura-Carro, G Colmenarejo, ... Science Advances 5 (3), eaav2104, 2019 | 121 | 2019 |